Pharmacokinetics and safety of CT-P17 (40 mg/0.4 ml) versus reference adalimumab: randomized study in healthy Japanese adults. Supplementary methods
收藏Taylor & Francis Group2024-05-16 更新2026-04-16 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Pharmacokinetics_and_safety_of_CT-P17_40_mg_0_4_ml_versus_reference_adalimumab_randomized_study_in_healthy_Japanese_adults_Supplementary_methods/22032608/1
下载链接
链接失效反馈官方服务：
资源简介：
Pharmacokinetics & safety of CT-P17 (40 mg/0.4 mL) vs reference adalimumab: randomised study in healthy Japanese adults: supplementary methods
提供机构：
Ogama, Yoichiro; Jeon, DaBee; Tanaka, Takanori; Bae, YunJu; Haranaka, Miwa; Kim, Sunghyun; Cha, JungBin; Lee, Sangmi; Choi, Eunjin
创建时间：
2023-02-07
